Acute Myeloid Leukemia (AML) is a fast-progressing cancer that affects blood and bone marrow. The goal of AML treatment is to achieve remission, a phase where the disease is no longer detectable in the body. However, remission does not always mean a cure, and ongoing monitoring is essential. Understanding the different types of remission and what they mean for patients can help in managing expectations and planning the next steps in treatment.
What Is Remission in AML?
Remission in AML means that the leukemia cells in the bone marrow and blood have been reduced to undetectable levels. It is typically determined by laboratory tests, bone marrow biopsies, and blood counts. However, remission does not guarantee that the cancer will not return.
Types of Remission in AML
1. Complete Remission (CR)
Complete remission means:
- No visible leukemia cells in the bone marrow (less than 5% blasts).
- Normal blood cell counts (white blood cells, red blood cells, and platelets).
- No leukemia symptoms.
Patients in complete remission may still have undetectable cancer cells, which is why further treatment or monitoring is needed.
2. Molecular Remission
Molecular remission means that even highly sensitive genetic tests cannot detect leukemia-related genetic mutations. This is a deeper level of remission than complete remission and indicates a lower risk of relapse.
3. Partial Remission
Partial remission means:
- A significant reduction in leukemia cells, but more than 5% blasts remain in the bone marrow.
- Some symptoms may still be present.
In this case, additional treatment may be needed to reach complete remission.
4. Minimal Residual Disease (MRD)-Negative Remission
MRD-negative remission means that specialized tests cannot detect any remaining leukemia cells. This is a very promising outcome because patients with MRD-negative remission have a lower chance of relapse.
5. Relapse After Remission
Relapse occurs when leukemia returns after a patient has been in remission. It can happen months or years after treatment and is usually confirmed through blood tests and bone marrow biopsies. If AML returns, further treatment options like chemotherapy, targeted therapy, or a stem cell transplant may be considered.
How Is Remission Achieved?
Achieving remission typically involves:
- Induction Therapy – The first phase of treatment aimed at destroying most leukemia cells and achieving initial remission.
- Consolidation Therapy – Follow-up treatment (such as additional chemotherapy or a stem cell transplant) to prevent relapse.
- Maintenance Therapy – Some patients receive ongoing lower-dose treatments to keep leukemia from returning.
Life After Remission
Even after remission, patients need regular follow-ups to monitor for any signs of relapse. This includes:
- Frequent blood tests and bone marrow exams.
- Managing long-term side effects of chemotherapy.
- Following a healthy lifestyle to support immune function.
Conclusion
Remission in AML is a crucial milestone, but it does not always mean the cancer is gone for good. Different levels of remission exist, and continued monitoring is essential to prevent relapse. Patients should work closely with their doctors to determine the best follow-up plan and treatment strategy to maintain remission and improve long-term outcomes.
